Eylea for wet agerelated macular degeneration eylea is a medication injected into the eye to treat wet amd. In addition, a smaller percentage of patients on eylea 36 percent required laser treatment for persistent edema that did not resolve with the antivegf treatment alone, compared to those on avastin 56 percent or lucentis 46 percent. Eylea was approved in the united states for the treatment of neovascular wet agerelated macular degeneration amd in 2011, and for the treatment of macular edema following central retinal vein occlusion crvo in 2012. The recommended dosage is two milligrams mg every two months, after five initial monthly injections. A 52yearold man presented for blurred vision in his right eye. Apr 30, 2015 cystoid macular edema cme in retinitis pigmentosa rp has been managed in several ways as documented in the literature, with little success, though.
Dme is the most common cause of diabetesrelated vision. Patient assistance program for eylea aflibercept injection. The following information is not intended to endorse any particular medication. Amd is a deterioration of the macula, a part of the retina which is responsible for sharp, detailed vision. Best drug to improve poor vision in diabetic macular edema. Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss. Includes eylea side effects, interactions and indications. Theres no cure for diabetic macular edema, but medications and procedures may reverse or slow the damage from this serious eye problem. This relieves the traction that is damaging the macula. Eylea aflibercept injection receives fda approval for the. A twoyear clinical trial that compared three drugs for diabetic macular edema dme found that gains in vision were greater for participants receiving the drug eylea aflibercept than for those receiving avastin bevacizumab, but only among participants starting treatment with 2050 or worse vision. May 09, 2017 eylea is an antivegf drug approved by the food and drug administration for treatment of crvoassociated macular edema. It is used to treat neovascular wet agerelated macular degeneration amd.
Eylea is also used to treat diabetic retinopathy, an eye disorder in diabetics that can lead to a buildup of fluid in the retina and cause blindness. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion. Eylea injections at 12 week intervals posted under eye health, low vision info there are two forms of age related macular degeneration amd, dry and wet, with wet amd being the less common one accounting for around 1015% of those with this retinal condition. Eylea aflibercept injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in eylea. This headtohead comparison of two widely used drugs for treatment of macular edema due to central retinal vein occlusion shows that both are effective in improving vision, said ingrid u.
Eylea is approved for treatment of wet agerelated macular degeneration, retinal vein occlusion with macular edema and diabetic macular edema. Eylea aflibercept injection is contraindicated in patients with ocular. Diabetic macular edema is a buildup of blood and fluid in the macula and can occur at any stage of diabetic retinopathy. The surgeon uses tiny instruments to remove the vitreous from the eye and peel scar tissue from the macula. Lucentis and avastin perform similarly to eylea when vision loss is mild, nih study shows. Study compares eylea, lucentis and avastin for diabetic macular. Neovascular wet agerelated macular degeneration amd 1. In patients with persistent diabetic macular edema, switching from an older vegf inhibitor to a newer one may improve outcomes. However, in certain diseases, such as wet agerelated macular degeneration, it is also associated with the growth of abnormal new blood vessels in the eye, which. Avastin as effective as eylea for treating central retinal. May 09, 2017 this headtohead comparison of two widely used drugs for treatment of macular edema due to central retinal vein occlusion shows that both are effective in improving vision, said ingrid u. Eylea injection treatment of macular degeration amdf. Intravitreal aflibercept for diabetic macular edema.
Aflibercept belongs to the class of medications called antineovascularization agents. The fda approves eylea injection for the treatment of diabetic. Eylea outperforms other drugs for diabetic macular edema. The european medicines agency noted that for wet amd eylea was as effective as ranibizumab in maintaining patients vision after the first year of treatment. Eylea outperforms avastin for diabetic macular edema with. Jun 21, 2019 eylea aflibercept is used to treat with neovascular wet agerelated macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy. Eylea is a prescription medicine approved by the food and drug administration for the treatment of dme, as well as diabetic retinopathy dr, wet agerelated macular degeneration wet amd and macular edema following retinal vein occlusion mefrvo.
Macular edema treatment american academy of ophthalmology. Regeneron pharmaceuticals announced that the fda has approved its eylea injection treatment for wet agerelated macular degeneration amd. When macular edema is caused by vitreous pulling on the macula, a procedure called a vitrectomy may be needed to restore the macula to its normal lying flat shape. Bestcorrected visual acuity bcva was 310 in his right. May 23, 2019 diabetic macular edema dme and diabetic retinopathy dr the data described below reflect exposure to eylea in 578 patients with dme treated with the 2mg dose in 2 doublemasked, controlled clinical studies vivid and vista from baseline to week 52 and from baseline to week 100 see clinical studies. The us food and drug administration fda has approved aflibercept eylea, regeneron pharmaceuticals injection solution to treat visual impairment caused by diabetic macular edema dme, the. Because the macula is the part of the eye needed for sharp, straightahead vision, damage to this area can cause dramatic vision problems. Diabetic macular edema edema a swelling or accumulation of fluid dme can occur in people with diabetes when retinal blood vessels begin. On july 29, 2014, the united states food and drug administration fda approved eylea generic name aflibercept for the treatment of diabetic macular edema. The retina is the lightsensitive tissue at the back of the eye and the macula is the part of the retina responsible for sharp, straightahead vision. Eylea is a vascular endothelial growth factor vegf inhibitor that treats neovascular wet agerelated macular degeneration amd, macular edema following retinal vein occlusion rvo, diabetic macular edema dme, and diabetic retinopathy dr. Safety profile of eylea aflibercept injection in dme. Eylea has been approved since august 2014 for treating visual impairment due to diabetic macular edema in adults. The aim of our study was to report for the first time in literature the use of aflibercept in a patient with rp and cme.
Fda oks aflibercept eylea for diabetic macular edema. Avastin is an fda approved biologic for treating cancer, but is frequently used offlabel to treat conditions of the eye, including. Diabetic macular edema dme is a disease that affects the macula the part of the retina responsible for sharp central vision. Bay865321 in patients with diabetic macular edema vista dme the safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Find answers to commonly asked questions about eylea aflibercept injection and diabetic macular edema dme. Momenta, mylan plan trial of biosimilar to regeneron eye. Diabetic macular edema dme, diabetic retinopathy dr in patients with diabetic macular edema dme. Side effects of eylea aflibercept, warnings, uses rxlist. The fda approves eylea injection for the treatment of.
The first round of results has been released from an ongoing study comparing current drug options for treatment of diabetic macular edema. You should not use eylea if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in eylea, including aflibercept. Eylea injections at 12 week intervals enhanced vision. Eylea is available as a single, 2mg strength intravitreal injection for all approved indications. To compare efficacy and safety of intravitreal aflibercept injection iai with macular laser photocoagulation for diabetic macular edema dme over 3 years. Eylea aflibercept solution for injection summary of product characteristics. Please see the full prescribing information for eylea. Eylea is the brand name for aflibercept, a drug that comes in the form of a liquid that is injected into the eye to treat wet agerelated macular degeneration wet amd, macular edema the buildup of fluids that causes swelling in the edema following retinal vein occlusion mefrvo, diabetic retinopathy dr, and diabetic macular edema dme. Diabetic macular edema dme occurs as a consequence of diabetes and is typically referred to as the leading cause of blindness in diabetic. In addition the agency considered that eylea was beneficial in improving vision of patients with macular oedema resulting from crvo, brvo or diabetes as well as patients with myopic. Eylea is also approved to treat macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy in patients with diabetic macular edema. Diabetic macular edema and eylea aflibercept injection. Nihfunded clinical trial shows eylea, avastin, and lucentis perform similarly when vision loss is mild. Eylea has also been approved in the eu and other countries for use in wet amd and macular edema following crvo.
In the eu and other countries, eylea is approved for the treatment of wet amd, macular edema following crvo, and dme. Jan 03, 2018 eylea is also approved to treat macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy in patients with diabetic macular edema. Momenta, mylan plan trial of biosimilar to regeneron eye drug. Aug 19, 2014 some good news for individuals who have diabetes and associated diabetic macular edema. Oct 05, 2016 effect of aflibercept eylea in the management of bevacizumab avastin resistant diabetic macular edema eylea the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Eylea is used to treat wet agerelated macular degeneration. Dec 11, 2018 interestingly, despite eylea being the last entrant in the antivegf segment, it has emerged as a patientshare leader in some g7 countries and generates billion dollar sales in the dme market in the g7. Fluid buildup causes the macula to swell and thicken, which distorts vision. It is also used to treat swelling in the retina caused by a blockage in the blood vessels. Study compares eylea, lucentis and avastin for diabetic.
The trial enrolled 660 participants with diabetic macular edema at 88 clinical trial sites across the u. Guidelines this policy defines coding and coverage for aflibercept including offlabel indications. These medications work by preventing the growth of new blood vessels. Macular edema following rvo and eylea aflibercept injection.
Jul 08, 2019 macular edema is the buildup of fluid in the macula, an area in the center of the retina. The fovea centralis is the part of the eye where our vision is the clearest, and the surrounding area is called the macula. Conversion to aflibercept may now be another option. The us food and drug administration fda has approved aflibercept eylea, regeneron pharmaceuticals injection solution to treat visual impairment. An eylea treatment plan can help you take on diabetic macular edema dme. Eylea aflibercept is a prescription medication for retinal diseases, which is injected into the eye. Bla 125387s061 page 4 food and drug administration. The following information is not intended to endorse drugs or recommend therapy. Macular edema is the medical term for fluid accumulation in the eyes retina. Fda approves eylea aflibercept injection for diabetic. Eylea aflibercept injection receives fda approval for. The macula center has expanded the array of leadingedge treatments available to diabetic patients with the additions of ozurdex and now, iluvien, two treatments for dme diabetic macular edema.
383 1465 84 785 484 1377 325 1228 175 715 1611 825 551 750 348 464 755 1068 502 65 1212 1692 885 1349 1083 1446 163 577 1152 817